Corto plazoMedio plazoLargo plazoSeñales

Nurix Therapeutics Inc [NRIX]

Bolsa: NASDAQ
Sector: Healthcare
Industria: Biotechnology
Última actualización 12 Jun 2026 @ 16:00 (Exchange is closed for the weekend)
Último: $16.95 -0.18%
0.82 (↑)
GaG Algo Score™
v1.0
Corto
0.82 (↑)
Medio
2.50 (↑)
Largo
2.08
COMPRAR
71.43%
rentabilidad 44.31%
VENDER
32.00%
rentabilidad 46.81%

Estadísticas

Volumen de hoy 2.56M
Volumen medio 1.68M
Capitalización 1.47B
BPA $-0.790 (Q1 | 2026-04-08)
Próxima fecha de resultados ($-0.730) 2026-07-09
PER -5.35 (Sector) 26.21 (Industria) 17.28
ATR14 $1.256 (7.41%)
Posible movimiento diario $16.32 - $17.58 (7.70%)

Niveles de soporte y resistencia

Línea

Datos pivot

Estadísticas pivot
Métrica Promedio Mediana Desv. est.
Ganancia % 26.45% 18.94% 23.53%
Pérdida % -13.21% -12.96% 4.79%
Duración 16.5d 16d 8.5d
Pivots encontrados 16
Tramos ganancia/pérdida 15 (8 Ganancia / 7 Pérdida)
Último pivot Top @ $17.76 el 2026-05-29
Cambio desde el último pivot $-0.81 (-4.56%)
Predicción del próximo pivot Último: $16.95
Próximo tipo previsto Bottom
Precio previsto (prom.) $15.41
Precio previsto (mediana) $15.46
Rango de precio previsto (~68%) $14.56 - $16.26
Cambio al objetivo promedio $-1.54 (-9.06%)
Fecha prevista (prom.) 2026-06-14
Rango de fechas previsto (~68%) 2026-06-06 - 2026-06-23
Base Based on 7 historical losses (Avg: -13.21%, Median: -12.96%, StdDev of Abs: 4.79%) and duration (Avg: 16.5 days, StdDev: 8.5 days)
Nota Ranges assume ~normal distribution & historical patterns repeat. Use with caution.

Nurix Therapeutics Inc edges lower, down -0.18%.

Nurix Therapeutics Inc (NRIX) stock price edged down slightly on Friday after the stock fell $-0.0300 (-0.18%) from the previous session on below-average volume. The stock slightly underperformed the market, lagging slightly behind the NASDAQ's 0.31% rise. Yesterday's trading volume was 2.56M shares, worth about $43.44M. This represents 1.47M shares less than the day before. Volume was below the 10-day average of 4.19M shares.

Nurix Therapeutics Inc signals

There is no conclusive signals given from RSI. The price is above both moving averages, but the short-term average remains below the long-term average; upward momentum is present but not yet fully confirmed. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (16.7%), medium- (16.7%), and long-term (16.7%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.

Nurix Therapeutics Inc Support & Resistance Levels

The stock is approaching the closest resistance level at $17.00. approximately $0.0500 (0.29%) away. Consolidating near resistance. Breaking above this level could signal further upside where next resistance level will be found at $19. On a fall back there will be support at $15.6 The dis das resistance s115.6 -

Nurix Therapeutics Inc Evaluation

  • Corto puntuación: 0.82
  • Medio puntuación: 2.50
  • Largo puntuación: 2.08